Idarubicin and ATRA is as effective as MRC chemotherapy in patients with acute promyelocytic leukaemia with lower toxicity and resource usage: Preliminary results of the MRC AML15 trial

被引：19

作者：

Burnett, Alan K. ^{[1
]}

Hills, Robert K. ^{[1
]}

Grimwade, David ^{[2
]}

Goldstone, Anthony H. ^{[3
]}

Hunter, Ann ^{[4
]}

Milligan, Don ^{[5
]}

Prentice, Archie G. ^{[6
]}

Russell, Nigel H. ^{[7
]}

Wheatley, Keith ^{[8
]}

机构：

[1] Cardiff Univ, Welsch Sch Med, Cardiff, Wales

[2] KCL, Sch Med, Dept Med & Mol Genet, London, England

[3] UCH, Sch Med, Dept Haematol, London, England

[4] Leicester Royal Infirm, Dept Haematol, Leicester, Leics, England

[5] Birmingham Heartlands Hosp, Dept Haematol, Birmingham, W Midlands, England

[6] Plymouth Hosp NHS Trust, Dept Haematol, Plymouth, Devon, England

[7] City Hosp, Dept Haematol, Nottingham, England

[8] Univ Birmingham, Birmingham Clin Trials Unit, Birmingham, W Midlands, England

来源：

关键词：

D O I：

10.1182/blood.V110.11.589.589

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

589

引用

页码：181A / 181A

页数：1